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An extensive review of sarcoidosis in 1952. re
ported that one of the characteristics of the disease
is the unaffected joints ( 8). However, a careful
reading of this article reveals gross photographs and
radiographs which are quite compatible with in
flammatory arthritis. In that same year it was em
phasized that sarcoidosis can present itself as ar
thritis ( 10). The association of sarcoidosis with
hilar adenopathy, erythema nodosum, and poly
arthritis was described in 1953 (Lofgren's Syn
drome) (7). Five cases of sarcoid arthritis were
reported by Sokoloff and Bunim in 1959, and
synovial granulomata were noted in three of the
five patients studied ( 12). Subsequently, a number
of articles have appeared in the literature reporting
the musculoskeletal involvement of sarcoidosis to
vary between 2.2 and 38% (9, 13). Usually asso
ciated with hilar adenopathy and erythema nodosum,
musculoskeletal sarcoidosis is less frequently linked
with transient arthritis, arthralgia, or periarticular
inflammation. Its relationship to destructive poly
arthritis, myopathy, or tendinitis is relatively un
common.
The discovery of the rheumatoid factor in
sarcoidosis ( 6, 11), coupled with the observed
musculoskeletal involvement, prompted a review of
our experience at the Medical College of Virginia.
The charts of 224 patients with sarcoidosis
were examined. Of the 224, those selected for our
study were at the time being followed as outpatients
because of their condition. Sixty such patients were
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available for personal observation and evaluation.
These 60 patients had been followed at MCV from
I to 372 months with an average of 46.8 months.
In making a histologic diagnosis of sarcoidosis,
we rely primarily on peripheral lymph nodes.
Excised palpable cervical, epitrochlear, and axillary
nodes have been our first choice for biopsy material.
In the absence of palpable lymph nodes, we usually
perform a scalene node biopsy, and in about 90%
of these cases, non-caseating granulomata have been
revealed when the clinical findings suggested sar
coidosis. In a few patients, a skin lesion has been
used as material for microscopic examination, but
in most cases when the skin has been biopsied
we have obtained a second source of material.
A lung biopsy has been performed in about 5%
of our patients; in most instances the clinical
manifestations were atypical, and a lung biopsy was
considered a better source of material for bac
teriological as well as for histological studies. We
generally have not relied on liver biopsies where the
yield of granulomata is around 75% ( I ).
The following serologic procedures were em
ployed.
I. Sensitized Sheep Cell (SSC): The SSC test
used was the Heller (4) modification of
the Waaler-Rose test. Test sera were ab
sorbed with unsensitized sheep cells and
diluted in saline. Sheep cells, from a con
stant source, were sensitized with I /20 the
basic agglutinin titer of rabbit anti-sheep
cell serum. Titers of I : 20 and above were
considered positive. The SSC test was
standardized in this way in order to obtain
relative specificity although it is not as
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sensitive a test as those used in other lab
oratories.
2. Sensitized Human Cell (SHC): A selected
DCe/DCe test cell was sensitized with Rip
ley serum (high-titered anti-DC), diluted
I : I 0. The Rh positive cells were sensitized
for 30 minutes at 37 ° C and then washed
three times with saline. Test sera were
titrated in saline in 0.1 ml volumes. Titers
of I : 20 or above were considered positive.
The SHC test was especially valuable in
obtaining reproducible titers of rheumatoid
factor in those individuals who were negative
with the SSC test.
3. Latex Test: This test was performed with
the commercial reagents supplied by the
Hyland Laboratories, Los Angeles, Cali
fornia. Reactions with the sera diluted I : 20
were considered positive.
The results of our studies are illustrated in
the accompanying tables. Table I lists the average
age of the patients when sarcoidosis was first diag
nosed. Of the 60 patients, 38 were Negro females
(63.3%).
Table 2 lists the presenting symptoms or why
a diagnosis of sarcoidosis was suspected. It is noted
that 22 of the 60 patients (36.6%) were asympto
matic, but sarcoidosis was suspected from screening
chest radiographs and was subsequently proved .
Table 3 lists the types of musculoskeletal in
volvement present in 19 patients. Nine of the 60
patients (IS%) presented with arthritis as the initial
manifestation of sarcoidosis. Five of these nine had
the syndrome of migratory arthritis, erythema nodo
sum, and radiographic findings of hilar and right
paratracheal lymphadenopathy. Two patients had
arthritis and an abnormal chest radiograph but did
not have erythema nodosum. One patient, a 20-ycar
old white female, had the recently described condition
of periarticular ankle inflammation and bilateral
hilar adenopathy (2). The arthritis and pul
monary radiographic findings cleared spontaneously
w1thm four weeks in eight of these nine patients.
One patient progressed to destructive polyarthritis

TA BLE 2. PRESENTING SYMPTOMS OR WHY SARCOIOOSIS WAS
SUSPECTED IN 60 PA TIENTS

Ages:
Av:

*

NM
9
( 14-48)
25

Only I patient over 52

NF
38
(13-72*)
28

WM
4
(27-61)
38

WF
9
(24-50)
35

4
4
3
2
2

which spontaneously entered a permanent remission
in two years.
Six of the remaining ten patients (32% of
total) developed short-lived arthralgia during their
course of follow-up. Four of the six progressed
from Stage I pulmonary disease (hilar lymphade
nopathy) to Stage 2 disease (hilar lymphadenopathy
and pulmonary infiltration). Two patients had Stage
I pulmonary disease which became normal in six
months.
The other four patients (21 % of total) de
veloped either short-lived oligo- or polyarthritis.
Three of these patients progressed from Stage I to
Stage 2 pulmonary disease. One patient progressed
from Stage 2 to Stage 3 (pulmonary infiltration and
fibrosis).
Other Organs Involved. Liver function studies,
other than serum protein determinations, were not
routinely performed. Liver biopsy was carried out
TA BLE
3. TYPES OF MUSCULOSKELETAL INVOLVEMENT
PRESENT IN]!) OF 60 P A TIENTS WITH S ARCOIDOSIS
I.
II.
I II.
IV.

TA BLE I. AGE, RACE, AND SEX OF 60 P ATIENTS WITH
SARCOIDOSIS

No.
22
7
6

Routine chest film
Chronic cough
Fever or undetermined origin
Erythema nodosum and arthritis
Uveitis
Arthritis
Lymphadenopathy
Dyspnea
9. Hoarseness
10. Fatigue
I.
2.
3.
4.
5.
6.
7.
8.

V.

Total:

Erythema nodosum, hilar adenopathy, arthritis
Total
NM
NF
WM
WF
5
4
Transient arthritis
WF
WM
NM
NF
Total
I
2
6
Transient arthralgia
WF
WM
NM
NF
Total
6
Periart. inflam. and hil. adenopathy
WF
WM
Total
NM
NF
I
Destructive polyarthritis
WF
WM
Total
NF
NM
I
I
0

11*

4

4

* The preponderance or Negro remales is in accord with
the observations or others.
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in only one patient, and this revealed non-caseating
granulomata. Marked hepatomegaly was noted in
three patients. Six patients had uveitis. One pa
tient had uveoparotid fever and one asymptomatic
parotid swelling. Laryngeal involvement in two
patients was manifested by hoarseness, and one
required a tracheostomy. Skin involvement of our
patients could not be evaluated since careful skin
examination was not performed at each visit. Only
three patients, however, were noted to have skin
involvement initially.
Synovial Fluid. Synovial fluid examination was
performed in only two patients. One patient was
a 25-year-old Negro female who entered the hos
pital because of fever of unknown origin. Poly
arthritis subsequently developed. Synovial fluid ex
amination revealed a poor mucin clot; leukocyte
count of 24,700/mm3 with 87% polymorphonuclear
cells and 13% mononuclear cells; sugar 30 mg per
100 ml; and protein 4.2 gms per JOO ml. No crystals
were observed. Percutaneous synovial biopsy re
vealed a non-specific chronic synovitis.
The other patient, a 30-year-old white male, had
Lofgren's syndrome. The mucin clot test was poor;
leukocyte count 42,500/mm'i with 90% polymor
phonuclear cells and 10% mononuclear cells; and
sugar 78 mg per 100 ml with simultaneous blood
sugar of 102 mg per 100 ml. No crystals were ob
served. Synovial fluid protein was not done. In
neither of these fluids was rheumatoid factor found.
Miscellaneous Blood Studies. Four of the 60
patients had peripheral leukocyte counts of less than
4,500/mm3. In none of these was there peripheral
lymphadenopathy or splenomegaly.
Serum calcium levels were determined in all
60 patients. In only one case was there an elevated
level-12.4 mg per 100 ml.
Serum uric acid levels were performed in all
19 of the patients with articular symptoms and in
23 of the other patients. No elevations were found.
Rheumatoid Factor and Serum Proteins. Re
active slide latex flocculation tests with negative
sensitized human cell tests were noted in only two
of the 60 patients (3.3%). One of these patients
was a 32-year-old Negro female with Stage 3 lung
disease (pulmonary infiltration and fibrosis) of at
least seven years' duration. Articular symptoms were
denied. The serum gamma globulin was diffusely
elevated. She was receiving long-term adrenocor
ticosteroids. The other patient was a 30-year-old
Negro female who had similar history and lab
oratory findings.
Serum protein electrophoresis was performed on
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47 of the 60 patients. An elevated gamma globulin
of the diffuse type was noted in 35 (74%).
Conclusion. Articular manifestations of sar
coidosis were present in 19 of our 60 patients
(32%). This correlates with previously reported
studies. In all of our cases but one, the articular
manifestations subsided in eight weeks. This fact
and the absence of hyperuricemia are in contra
distinction to other studies for which we have no
adequate explanation ( 13, 5, 3).
The finding of reactive latex flocculation tests
in only two of 60 patients is an interesting observa
tion and deserves further comment.
It has become apparent that rheumatoid factors
are not abnormal antibodies but rather normal serum
components present in low titer in normal as well
as diseased persons. These "heterophile" anti
globulin antibodies reach their highest titers in
rheumatoid arthritis, and the diagnostic value of
high titers of these antibodies may be compared
with the diagnostic value of titers of another het
erophile, the anti-sheep erythrocyte antibody and
the associated disease, infectious mononucleosis.
Positive slide latex tests have very little diag
nostic value except possibly in the negative sense.
The percentage of positive tests in a non-rheumatic
population is apparently related to the degree of
hypergammaglobulinemia.
In our geographic area, the young Negro fe
male, in accordance with our study, was most prone
to sarcoidosis. This segment of the population is
not characterized by an unusually high incidence
of positive latex tests, and thus we were not sur
prised to find that our patients with sarcoidosis did
not show an increased incidence of positive tests
for rheumatoid factor. None of these patients showed
positive SHC or SSC tests.
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